EGFR and neoplasm: It should be noted that tumor cells in which the p.Cys797Ser and p.Thr790Met variants occur together in the cis-configuration (on the same allele) were shown to be insensitive to currently approved EGFR-TKIs, including third-generation EGFR-TKIs [12].